News
Stay up to date with MEGIN’s latest news, including customer announcements, press releases, and the MEGIN Matters newsletter.
Subscribe to MEGIN Matters
Don’t miss the latest MEG insights and MEGIN news – complete the form below to be added to our mailing list and receive MEGIN Matters right in your inbox!
Explore news
MEGIN Matters – February 2025
We were proud to join our strategic partners BESA GmbH at Arab Health this January! MEGIN, together with Aalto University, publishes research that could streamline MEG/EEG source imaging.
MEGIN Matters – January 2025
As we begin 2025, MEGIN is excited to continue our commitment to innovation, excellence, and collaboration to further MEG in neuroscience.
MEGIN Matters – December 2024
This year at MEGIN we celebrated the launch of our new MEG Maps™ platform*, installed new sites, and strengthened our strategic partnerships.
MEGIN Matters – November 2024
MEGIN is delighted to be offering workshop sessions at AES with our strategic partners and early adopter, exploring our new MEG Maps™ Platform*.
MEGIN Matters – October 2024
Norman Fixel Institute for Neurological Diseases at University of Florida Health, celebrates 1 year of the TRIUX™ neo scanner and their 100th MEG scan!
MEGIN Matters – September 2024
MEGIN team members present their work at BIOMAG 2024 in Sydney and we attend ASFNR with one of our strategic partners, FIND Neuro.
MEGIN Matters – August 2024
MEGIN begins to offer demos of the MEG Maps™ platform at events, and heads out to Boston to support the Pediatric Epilepsy Surgery Alliance (PESA) family conference.
MEGIN Matters – July 2024
MEGIN achieves new FDA 510(k) clearance for all components of MEG Maps™ and is featured in a video showing the cutting-edge installations now operational at Campus Biotech in Geneva.
MEGIN’s MEG Maps™ to transform the field of neuroscience, a field that is still limited by the performance of conventional neuroimaging modalities to date
MEGIN, a leader in functional neuroimaging technology, made a significant announcement today by unveiling MEG Maps™, a cutting-edge neuroimaging scanner platform. All the...
MEGIN Matters – June 2024
MEGIN was proud to sponsor the ILAE School on Neuroimaging 2024 (AMIE & SuSIE 2024) held in Potsdam, Germany, this month.
MEGIN Matters – May 2024
Learn more about MEG, how it is utilised, and the expanding scope of MEG clinical research, as well as insights about MEGIN and the TRIUX™ neo.
MEGIN Matters – April 2024
MEGIN is thrilled to announce the installation of the TRIUX™ neo at Barrow Neurological Institute, recently recognized in Newsweek World's Best Hospitals, Neurosurgery 2024. We...
MEGIN Matters – March 2024
We are happy to announce the kickoff of our collaborative project with FIND Neuro!In this project, FIND Neuro will develop a platform to improve MEG utilization for pre-surgical...
Westcan Proton Therapy Inc. will establish Canada’s first proton therapy facility in Edmonton, Alberta in coordination with MEGIN and other industry leading partners
EDMONTON, AB – WestCan Proton Therapy Inc. has announced their plans to invest in Canada’s first proton therapy treatment centre to be built in Edmonton. The centre will...
MEGIN Matters – February 2024
We were pleased to present “MEGnificent brain discoveries,” showcasing innovative applications of MEG neuroimaging technology. Featuring three keynote lectures by leading...